Structure |
Chemical Name |
CAS |
MF |
![(6-methyl-2-p-tolyl-2,3-dihydro-imidazo[1,2-a]pyridin-3-yl)-oxoacetic acid](/CAS/20200401/GIF/927820-48-2.gif) |
(6-methyl-2-p-tolyl-2,3-dihydro-imidazo[1,2-a]pyridin-3-yl)-oxoacetic acid |
927820-48-2 |
C17H14N2O3 |
 |
Eseroline |
469-22-7 |
C13H18N2O |
 |
Methyl 5-amino-2,4-difluorobenzoate |
125568-73-2 |
C8H7F2NO2 |
 |
β-AMino-α-hydroxycyclobutanebutanaMide Hydrochloride |
394735-23-0 |
C8H17ClN2O2 |
 |
Methyl 2-(2,3-dichlorobenzylidine)acetoacetate |
74073-22-6 |
C12H10Cl2O3 |
 |
methyl (4-(5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)-2-methylbenzoyl)glycinate |
864731-38-4 |
C21H17Cl2F3N2O4 |
 |
5-(2-chloroethyl)-2,3-dihydrobenzofuran |
943034-50-2 |
C10H11ClO |
![Benzoic acid, 4-[1-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)ethenyl]-, methyl ester](/CAS2/GIF/153559-48-9.gif) |
Benzoic acid, 4-[1-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)ethenyl]-, methyl ester |
153559-48-9 |
C25H30O2 |
![(3R,3αS,6αR)-Hexahydrofuro[2,3-β]furan-3-yl-4-nitrophenyl carbonate](/CAS/20180808/GIF/252873-35-1.gif) |
(3R,3αS,6αR)-Hexahydrofuro[2,3-β]furan-3-yl-4-nitrophenyl carbonate |
252873-35-1 |
C13H13NO7 |
 |
2-(methylamino)pyridin-3-yl)methyl 2-((tert-butoxycarbonyl)(methyl)amino)acetate |
1180002-01-0 |
C15H23N3O4 |
 |
Fluvis group intermediate |
|
|
 |
Isavuconazole Impurity |
338990-63-9 |
C40H43ClF2N8O7S |
 |
Eribulin intermediateB |
|
|
 |
6-Chlor-2,3,4,5-tetrahydro-7,8-dimethoxy-1-(4-methoxyphenyl)-1H-3-benzazepin |
67287-53-0 |
C19H22ClNO3 |
 |
METHYL ESTER, 4,5-BIS(2-METHOXYETHOXY)-2-NITROBENZOIC ACID |
501684-22-6 |
C14H19NO8 |
![(7a,17b)-7-[9-[(4,4,5,5,5-Pentafluoropentyl)thio]nonyl]-estra-1,3,5(10)-triene-3,17-diol](/CAS2/GIF/153004-31-0.gif) |
(7a,17b)-7-[9-[(4,4,5,5,5-Pentafluoropentyl)thio]nonyl]-estra-1,3,5(10)-triene-3,17-diol |
153004-31-0 |
C32H47F5O2S |
 |
(αR,βR)-β-(2,5-Difluorophenyl)-β-hydroxy-α-Methyl-1H-1,2,4-triazole-1-butanoic Acid |
483340-19-8 |
C13H13F2N3O3 |
 |
Derivatives intermediate 2 |
1213710-57-6 |
C26H38N2O3 |
 |
Pluronic PE 4300 |
|
|
 |
Entecavir hydrate |
|
|
 |
2-(2-HYDROXYPHENYL)-4H-1,3-BENZOXAZIN-4-ONE |
1218-69-5 |
C14H9NO3 |
 |
Olmesartan intermediate |
|
|
![(1s-trans)-2-[(phenylmethoxy)methyl]-3-cyclopenten-1-ol](/CAS/GIF/188399-48-6.gif) |
(1s-trans)-2-[(phenylmethoxy)methyl]-3-cyclopenten-1-ol |
188399-48-6 |
C13H16O2 |
 |
(S)-2-(((3R,4R)-4-(3-Hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)methyl)-3-phenylpropanoic acid methyl ester hydrochloride |
170098-28-9 |
C24H31NO3.HCl |
![tert-butyl [(2R,3S)-2-(2,5-difluorophenyl)-5-hydroxytetrahydro-2H-pyran-3-yl]carbaMate](/CAS/20150408/GIF/1172623-99-2.gif) |
tert-butyl [(2R,3S)-2-(2,5-difluorophenyl)-5-hydroxytetrahydro-2H-pyran-3-yl]carbaMate |
1172623-99-2 |
C16H21F2NO4 |
 |
,100kg |
180048-73-1 |
C11H14O4S |
![4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-2-methylbenzoic acid](/CAS/20180529/GIF/864725-62-2.gif) |
4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-2-methylbenzoic acid |
864725-62-2 |
C18H12Cl2F3NO3 |
 |
Ozagrel sodium |
130952-46-4 |
C13H13N2NaO2 |
![(2S,5R)-6-(tert-butyldimethylsilyloxy)-3-methyl-7-oxo-1,6-diazabicyclo[3.2.1]oct-3-ene-2-carboxamide](/CAS/20210305/GIF/2209874-02-0.gif) |
(2S,5R)-6-(tert-butyldimethylsilyloxy)-3-methyl-7-oxo-1,6-diazabicyclo[3.2.1]oct-3-ene-2-carboxamide |
2209874-02-0 |
C14H25N3O3Si |
![1,6-Diazabicyclo[3.2.1]oct-3-ene-2-carboxamide, 6-hydroxy-3-methyl-7-oxo-, (1R,2S,5R)-](/CAS/20210305/GIF/2209874-17-7.gif) |
1,6-Diazabicyclo[3.2.1]oct-3-ene-2-carboxamide, 6-hydroxy-3-methyl-7-oxo-, (1R,2S,5R)- |
2209874-17-7 |
C8H11N3O3 |
![2-(1-(ethylsulfonyl)-3-(4-(7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile](/CAS/20180531/GIF/1187594-13-3.gif) |
2-(1-(ethylsulfonyl)-3-(4-(7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile |
1187594-13-3 |
C22H31N7O3SSi |
 |
Derivatives intermediate 3 |
1213710-50-9 |
C21H30N2O |
 |
(2S,3R)-2-amino-3-methylpent-4-enamide |
2209873-96-9 |
C6H12N2O |
![(1S,2R,3S,5R)-2-(Benzyloxymethyl)-6-oxabicyclo[3.1.0]hexan-3-ol](/CAS/GIF/117641-39-1.gif) |
(1S,2R,3S,5R)-2-(Benzyloxymethyl)-6-oxabicyclo[3.1.0]hexan-3-ol |
117641-39-1 |
C13H16O3 |
![(6β)-3-(1-Methyl-1H-tetrazole-5-ylthiomethyl)-7α-amino-7-methoxy-8-oxo-5-oxa-1-azabicyclo[4.2.0]octa-2-ene-2-carboxylic acid benzhydryl ester](/CAS/GIF/66510-99-4.gif) |
(6β)-3-(1-Methyl-1H-tetrazole-5-ylthiomethyl)-7α-amino-7-methoxy-8-oxo-5-oxa-1-azabicyclo[4.2.0]octa-2-ene-2-carboxylic acid benzhydryl ester |
66510-99-4 |
C24H24N6O5S |
 |
(S)-1-(2-(1-aMino-2-Methylpropan-2-ylaMino)acetyl)pyrrolidine-2-carbonitrile dihydrochloride (AMino pyrrolidine) |
739364-93-3 |
C11H22Cl2N4O |
![(4-(1-(3-(cyanomethyl)-1-(ethylsulfonyl)azetidin-3-yl)-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate](/CAS/20200331/GIF/1187595-90-9.gif) |
(4-(1-(3-(cyanomethyl)-1-(ethylsulfonyl)azetidin-3-yl)-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate |
1187595-90-9 |
C22H27N7O4S |
 |
Danshen injection intermediate |
|
|
 |
Flomoxef Intermediate FXMT |
|
|
![Platinum, dichloro(1,2-cyclohexanediamine-N,N')-, [sp-4-2-(1R-trans)]-](/CAS/20180713/GIF/61848-66-6.gif) |
Platinum, dichloro(1,2-cyclohexanediamine-N,N')-, [sp-4-2-(1R-trans)]- |
61848-66-6 |
C6H12Cl2N2Pt |
![(3R,3αS,6αR)-Hydroxyhexa-hydrofuro[2,3-β]furan-3-yl acetate](/CAS/20180808/GIF/186488-43-7.gif) |
(3R,3αS,6αR)-Hydroxyhexa-hydrofuro[2,3-β]furan-3-yl acetate |
186488-43-7 |
C8H12O4 |
 |
Cabazitaxel N-3 |
859498-31-0 |
C57H61Cl6NO19 |
 |
tetramethyl 3,3',3'',3'''-(porphyrin-5,10,15,20-tetrayl)tetrabenzoate |
75286-83-8 |
C52H38N4O8 |
 |
Dabigatran intermediate |
|
|
![(7alpha,17beta)-17-(Acetyloxy)-7-[9-[(4,4,5,5,5-pentafluoropentyl)thio]nonyl]estr-4-en-3-one](/CAS/20150408/GIF/415927-29-6.gif) |
(7alpha,17beta)-17-(Acetyloxy)-7-[9-[(4,4,5,5,5-pentafluoropentyl)thio]nonyl]estr-4-en-3-one |
415927-29-6 |
C34H51F5O3S |
 |
Engelide intermediate |
|
|
 |
Material intermediate |
162039-67-0 |
C18H14N4 |
 |
FLUTICASONE PROPIONATE INTERMEDIATE |
80474-45-9 |
C24H30F2O5S |
 |
Dolutegravir intermediate |
|
|
![4-[3-(Trifluoromethyl)phenyl]-1-piperazineethanol](/CAS/GIF/40004-29-3.gif) |
4-[3-(Trifluoromethyl)phenyl]-1-piperazineethanol |
40004-29-3 |
C13H17F3N2O |
![(4aS,7aS)-octahydropyrrolo[3,4-b][1,4]oxazine](/CAS/20150408/GIF/209401-69-4.gif) |
(4aS,7aS)-octahydropyrrolo[3,4-b][1,4]oxazine |
209401-69-4 |
C6H12N2O |
 |
Eribulin intermediate |
157322-47-9 |
C21H35IO4 |
 |
Flomoxef Intermediate F3-01 |
|
|
![5-Pyrimidineacetamide, 2-butyl-1-[(2'-cyano[1,1'-biphenyl]-4-yl)methyl]-1,6-dihydro-N,N,4-trimethyl-6-oxo-](/CAS/20210111/GIF/1985668-78-7.gif) |
5-Pyrimidineacetamide, 2-butyl-1-[(2'-cyano[1,1'-biphenyl]-4-yl)methyl]-1,6-dihydro-N,N,4-trimethyl-6-oxo- |
1985668-78-7 |
C27H30N4O2 |
 |
Triazinate |
41191-04-2 |
C23H31ClN6O5S |
 |
Side chain of Cefotetan |
955010-42-1 |
C10H13NO5S2 |
 |
5-Methoxy cytidine |
37805-90-6 |
C10H15N3O6 |
 |
Cefaloram |
859-07-4 |
C18H18N2O6S |
 |
Cefetrizole |
65307-12-2 |
C16H15N5O4S3 |
![1-[((7R)-7-AMINO-4-CARBOXY-3,4-DIDEHYDROCEPHAM-3-YL)METHYL]-1H-IMIDAZO[1,2-B]PYRIDAZIN-4-IUM IODIDE](/CAS/GIF/197897-11-3.gif) |
1-[((7R)-7-AMINO-4-CARBOXY-3,4-DIDEHYDROCEPHAM-3-YL)METHYL]-1H-IMIDAZO[1,2-B]PYRIDAZIN-4-IUM IODIDE |
197897-11-3 |
C14H14IN5O3S |
![(1α,2β,5α)-2,6,6-Trimethylbicyclo[3.1.1]heptan](/CAS/GIF/6876-13-7.gif) |
(1α,2β,5α)-2,6,6-Trimethylbicyclo[3.1.1]heptan |
6876-13-7 |
C10H18 |
 |
D-α-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-β-(S)-tert-butoxybutyric acid |
79276-23-6 |
C15H25N3O6 |
 |
Cefovecin |
234096-34-5 |
C17H19N5O6S2 |
 |
Cephalexin ethyl homologue |
|
|
 |
Pinanylhydroperoxid |
28324-52-9 |
C10H18O2 |
 |
Cefuroxime double mother nucleus |
|
|
 |
Cefotifuromercapto |
|
|
 |
Cephalexin Tablets |
|
|
 |
△3-Cefuroxime |
|
|
 |
Cefaclor, Delta-3 IsoMer |
|
|
 |
Cefmetazole Impurity 4 |
68576-47-6 |
C15H17N7O4S4 |
 |
Anti-Ceftriaxong |
|
|
 |
Cefuroxime Impurity 1(Cefuroxime Mother Nucleus) |
|
|
 |
Δ3-Ceftiofur |
|
|
 |
8-Benzyloxy-2'-deoxy-D-guanosine |
96964-90-8 |
C17H19N5O5 |
 |
Cefetecol |
117211-03-7 |
C20H17N5O9S2 |
 |
Δ3-Flomoxef sodium |
|
|
 |
2,10-Epoxypinan |
6931-54-0 |
C10H16O |
 |
Ceftazidime and Avibactam Sodium for Injection |
|
|
 |
(6R,7S)-Ceftriaxone Epimer |
|
|
 |
Cefcanel |
41952-52-7 |
C19H18N4O5S3 |
 |
(6R,7S)-Cefuroxime |
|
C16H16N4O8S |
 |
Cefazolin Related Compound D |
|
|
 |
Ceftazidime Mother Nucleus Double-Bond Shift |
|
|
 |
L-Cephalexin |
34632-04-7 |
C16H17N3O4S |
 |
7-AMINO-3-(2-FUROYLTHIOMETHYL)-3-CEPHEM-4-CARBOXYLIC ACID |
80370-59-8 |
C13H12N2O5S2 |
 |
Cefradine double nucleus |
|
|
 |
CEFMETAZOLE MMT ISOMER |
|
|
 |
Cefminox for system suitability |
|
|
 |
Cefiderocol |
1225208-94-5 |
C30H34ClN7O10S2 |
![[1R-(1α,2α,5α)]-2,6,6-Trimethylbicyclo[3.1.1]heptan](/CAS/GIF/4863-59-6.gif) |
[1R-(1α,2α,5α)]-2,6,6-Trimethylbicyclo[3.1.1]heptan |
4863-59-6 |
C10H18 |
 |
Cefotiam (6R,7S) isomer reference |
|
|
 |
Ceftiofur Double Mother Nucleus |
|
|
 |
7S-Cephalexin |
|
|
 |
(6R,7S)-Latamoxef MotherNucleus |
|
|
![(6R-trans)-3-(Acetoxymethyl)-7-[(2-aminothiazol-4-yl)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-2-carbonsure](/CAS/GIF/58233-18-4.gif) |
(6R-trans)-3-(Acetoxymethyl)-7-[(2-aminothiazol-4-yl)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-2-carbonsure |
58233-18-4 |
C15H16N4O6S2 |
 |
(7S)-Cefuroxime |
|
|
 |
6R,7S-Ceftazidime isomer |
|
|
 |
Ceftiofur Double Side Chain |
|
|
 |
Cephalosporin |
11111-12-9 |
C16H21N3O8S |